Adalimumab and Tofacitinib Combination Therapy for Pyoderma Gangrenosum: A Case Report
Case Reports in Dermatology · 06.03.2026 · 18 (1) · 177-181
DOI: 10.1159/000550618 ↗Kurz gefasst
Fallbericht in der Zeitschrift Case Reports in Dermatology, online erschienen am 06.03.2026. Verfasst von Jingjing Yang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Longhua District People's Hospital, Shenzhen, China. Die Arbeit nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Pyoderma gangrenosum (PG) is a rare inflammatory skin disease causing progressive necrotizing ulcers with limited treatment options due to adverse effects and high recurrence rates. Case Presentation: We present a case of a 70-year-old elderly patient diagnosed as PG, which was unresponsive to initial prednisolone treatment. After approximately 3 weeks of an individualized treatment regimen of adalimumab combined with tofacitinib, disease progression was halted, accompanied by a significant reduction in ulcer size, reduced exudation, and substantial pain relief. Subsequent tapering and discontinuation of prednisolone, followed by 6 weeks of combined adalimumab and tofacitinib and 8 weeks of tofacitinib monotherapy, resulted in complete ulcer healing by week 17. No recurrence of inflammatory activity was observed during the follow-up period of over 7 months.
Conclusion
This case highlights the successful and rapid efficacy of adalimumab and tofacitinib combination therapy for PG, offering a novel strategic reference for individualized treatment, particularly in recurrent or cases unresponsive to initial treatment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, Longhua District People's Hospital, Shenzhen, China.
Zitieren
APA
Yang, J., Zhou, S., & Liu, C. (2026). Adalimumab and Tofacitinib Combination Therapy for Pyoderma Gangrenosum: A Case Report. Case Reports in Dermatology, 18(1), 177-181. https://doi.org/10.1159/000550618
Vancouver
Yang J, Zhou S, Liu C. Adalimumab and Tofacitinib Combination Therapy for Pyoderma Gangrenosum: A Case Report. Case Reports in Dermatology. 2026;18(1):177-181. doi:10.1159/000550618
BibTeX
@article{Yang2026,
author = {Yang, Jingjing and Zhou, Shunlong and Liu, Chao},
title = {Adalimumab and Tofacitinib Combination Therapy for Pyoderma Gangrenosum: A Case Report},
journal = {Case Reports in Dermatology},
year = {2026},
volume = {18},
number = {1},
pages = {177--181},
doi = {10.1159/000550618}
}
EUVIMED